Pfizer-BioNTech says their COVID-19 vaccine is 100% efficacious in protecting adolescents aged 12 to 15 years from COVID-19 disease.
On March 31, the companies released a statement summarizing the results of their study of the safety and efficacy of their vaccine, which is already authorized in the U.S. and elsewhere for use in adults 16 years or older, in this younger age group. The results have been highly anticipated as state and local leaders—not to mention parents—are to keen send teens back to in-person school; this study suggests a path towards a return to pre-pandemic learning conditions, in which students won’t spread COVID-19 in the classroom.
